Liaoning Chengda Biotechnology CO., LTD

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies Against Japanese Encephalitis	Japanese Encephalitis Vaccine	Active, not recruiting	Phase 4	2026-09-02	NCT06825312
Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations	Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms	Recruiting	Not stated	2025-08-13	NCT07120464
Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas	Encephalitis, Arbovirus, Encephalitis, Viral, Flaviviridae infectious disease, Flavivirus Infections, Infections, Japanese encephalitis, Mosquito-Borne Diseases, Neuroinflammatory Diseases, RNA Virus Infections, arbovirus infection, brain disorder, central nervous system disorder, central nervous system infectious disorder, encephalitis, infectious encephalitis, nervous system disorder, vector-borne disease, viral infection of central nervous system, viral infectious disease	Active, not recruiting	Phase 4	2024-12-13	NCT06678373

Clinical trials